drugset / Trial / NCT03239964

Surgical Excision and Intralesional Steroid Injection for Prevention of Post Caesarean Keloid Recurrence

NCT03239964 ↗

Phase 4 Completed 146 enrolled Kasr El Aini Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

Two groups of patients (73 patients each) undergoing routine caesarean section has recurrent keloid at site of surgical scar. One group will undergo surgical excision of keloid. The other group will have combined surgical excision of keloid and single intralesional dexamethasone injection at edges of wound.All patients were reviewed once per month for 6 months for evidence of recurrence

Timeline

Start
2016-08-10
Primary completion
2018-01-24
Completion
2018-01-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 4 mg/ml Other

Indications